Kedrion: at ESID 2026, experts call for earlier diagnosis and greater awareness as Secondary Immunodeficiencies continue to rise
MAASTRICHT, Netherlands, Oct. 14, 2026 /PRNewswire/ -- Secondary Immunodeficiencies (SIDs) represent a significant and frequently under-recognized healthcare challenge. Their clinical relevance has increased with the expanding use of immunosuppressive and biologic therapies, advances in...
Read original article on All News Releases →